Guangdong Hybribio Biotech Co.,Ltd. (SHE:300639)

China flag China · Delayed Price · Currency is CNY
5.10
+0.05 (0.99%)
Apr 30, 2025, 3:04 PM CST
-18.79%
Market Cap 3.24B
Revenue (ttm) 815.53M
Net Income (ttm) -654.88M
Shares Out 636.08M
EPS (ttm) -1.02
PE Ratio n/a
Forward PE 18.89
Dividend 0.07 (1.29%)
Ex-Dividend Date May 23, 2024
Volume 4,600,166
Average Volume 7,145,212
Open 5.13
Previous Close 5.05
Day's Range 5.04 - 5.16
52-Week Range 4.32 - 8.33
Beta 0.58
RSI 42.03
Earnings Date Apr 29, 2025

About SHE:300639

Guangdong Hybribio Biotech Co.,Ltd. engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes. It provides in-vitro diagnostic kits for human papilloma virus, sexually transmitted diseases (STD), thalassemia, and prenatal and postnatal. The company also offers STD real time PCR kits; hepatitis B virus real-time PCR kits and thalassemia genoarray diagnostic kits; hearing loss susceptibility genoarray diagnostic kits; COVID-19 real-time PCR kits; and devices/i... [Read more]

Sector Healthcare
Founded 2003
Employees 2,669
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300639
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.